BeStock  
Stocks › Biotechnology › IMMX

Immix Biopharma IMMX

US equityMarket cap rank #3420Biotechnology
$9.49 −$0.15 (-1.56%)
Pre-market · Oct 8, 8:50 am ET · After hours $9.49 0.00%
Open$9.50
Prev close$9.64
Day range$9.40 – $9.69
Volume1.38M
Market cap$788.42M
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

Technical signals

Trend readLeaning bearish

2 bullish · 5 bearish of 7 signals

IndicatorValueSignalReading
Price vs 20-day average-16.7%BearishTrading below the 20-day average of $11.39
Price vs 50-day average-18.7%BearishTrading below the 50-day average of $11.67
Price vs 200-day average+3.1%BullishTrading above the 200-day average of $9.21
50-day vs 200-day50d above 200dBullishThe 50-day average is above the 200-day average
RSI (14)32.7BearishMomentum leans negative
MACD (12,26,9)-0.70BearishMACD line is below its signal line
Bollinger band position8%BearishInside the 20-day bands

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Levels & volatility

Moving averages

AverageLevelPrice vs. it
20-day SMA$11.39-16.7%
50-day SMA$11.67-18.7%
200-day SMA$9.21+3.1%

Recent price levels

LevelPrice
20-day high$13.29
20-day low$9.40
60-day high$15.10
60-day low$7.83
Upper Bollinger band$13.68
Lower Bollinger band$9.10

The 50-day average is currently 26.8% above the 200-day average — consistent with a “golden cross” (bullish) configuration.

30-day volatility58.8%
Average true range8.87% of price
Max drawdown (1y)-39.8%
Volume (10d vs 90d)1.18x

Discussion

No comments yet — be the first to weigh in on IMMX.

Leave a comment

Scroll to Top